Angiodynamics Inc. (ANGO)
Market Closed
17 Jul, 20:00
$
13. 51
-0.63
-4.4554%
$
528.47M Market Cap
- P/E Ratio
- Div Yield
497,278 Volume
-0.39 Eps
$ 14.14
Previous Close Want to track ANGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ANGO closed today lower at $13.51, a decrease of -4.4554% from yesterday's close, completing a monthly increase of 3.6043% or $0.47. Over the past 12 months, ANGO stock gained 4.9728%.
ANGO is not paying dividends to its shareholders.
The last earnings report, released on Mar 31, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.061%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
AngioDynamics: Growth Is Working, Price Knows It (Rating Downgrade)
AngioDynamics develops tools for minimally invasive procedures across blood flow, blocked arteries, and prostate cancer treatment. Key offerings include AlphaVac and AngioVac for clot removal, Auryon for arterial plaque, and NanoKnife for prostate cancer. After a prolonged period of stagnation, ANGO shares are finally showing signs of positive momentum.
Seekingalpha | 1 day ago
AngioDynamics Q4 Earnings Beat Estimates, Gross Margin Expands
ANGO's Q4 FY26 revenues rise 8% as Med Tech surges, while its adjusted loss beats estimates and FY27 sales guidance tops consensus.
Zacks | 2 days ago
AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript
AngioDynamics, Inc. (ANGO) Q4 2026 Earnings Call Transcript
Seekingalpha | 3 days ago
Angiodynamics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TMB Timothy M. Bidwell Hazlett, BURT & WATSON Inc. | 157 | $1,753.69 | $2,263.94 | $510.25 | 29.1% |
| CE Curtis Ellergodt Rothschild Investment LLC | 44 | $565 | $634.48 | $69.48 | 12.3% |
| BG Bart Gancher Intech Investment Management LLC | 13,442 | $124,078.39 | $194,072.91 | $69,994.52 | 56.41% |
| KAC Kimberly A. Clarke Stoneridge Investment Partners LLC | 14,882 | $169,000 | $214,863.34 | $45,863.34 | 27.14% |
 Anthony Scaramucci SkyBridge Capital II LLC | 1.87M | $17.67M | $26.9M | $9.22M | 52.17% |
Angiodynamics Inc. (ANGO) FAQ
What is the stock price today?
The current price is $13.51.
On which exchange is it traded?
Angiodynamics Inc. is listed on NASDAQ (NGS).
What is its stock symbol?
The ticker symbol is ANGO.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 528.47M.
Has Angiodynamics Inc. ever had a stock split?
No, there has never been a stock split.
Angiodynamics Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | James C. Clemmer CEO | NASDAQ (NGS) Exchange | 03475V101 CUSIP |
| US Country | 748 Employees | - Last Dividend | - Last Split | 27 May 2004 IPO Date |
Overview
AngioDynamics, Inc. is a prominent provider of invasive medical devices, catering to the needs of professional healthcare providers across the United States and internationally. The company specializes in a broad spectrum of medical areas, including vascular access, surgery, peripheral vascular disease, and oncology. Established in 1988, AngioDynamics is committed to enhancing patient outcomes through its innovative technologies and solutions, headquartered in Latham, New York.
Products and Services
- Auryon Atherectomy System: A cutting-edge solution for the treatment of peripheral arterial disease. This system utilizes an optimized wavelength, pulse width, and amplitude to efficiently remove lesions while preserving the vessel wall endothelium.
- Thrombus Management Portfolio:
- AlphaVac System: A mechanical aspiration device designed for emergent situations, obviating the need for perfusionist support.
- Thrombolytic Catheters: These are used to deliver drugs known as thrombolytic agents, intended to dissolve blood clots found in hemodialysis access grafts, arteries, veins, and surgical bypass grafts.
- AngioVac Circuit: Designed for extracorporeal circulatory support for up to six hours. This includes a pump, filter, and reinfusion cannula to facilitate venous drainage during bypass procedures.
- NanoKnife IRE Ablation System: Offers a non-traditional thermal approach for the surgical ablation of soft tissue, providing an alternative to conventional methods.
- Peripheral Products: This category includes a range of products such as angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. These are essential tools for peripheral diagnostic and interventional procedures.
- Drainage Catheters: A diverse range of catheters for various purposes, including multi-purpose/general, nephrostomy, and biliary drainage.
- Micro Access Kits: Provides interventional physicians with a smaller introducer system for conducting minimally invasive procedures.
- VenaCure EVLT System: Utilized in endovascular laser procedures to treat superficial venous disease, showcasing the company's commitment to vascular health.
- Solero MTA System: Comprising the Solero microwave generator and specially designed Solero MW applicators, this system targets microwave thermal ablation processes.
Contact Information
Address: 14 Plaza Drive
Phone: 518 795 1400
Website: https://www.angiodynamics.com
